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Abstract Ribosome biogenesis is both necessary for cellular
adaptation, growth, and proliferation as well as a major energetic
and biosynthetic demand upon cells. For these reasons, ribosome
biogenesis requires precise regulation to balance supply and
demand. The complexity of ribosome biogenesis gives rise to
many steps and opportunities where regulation could take place.
For trans-acting factors involved in ribosome biogenesis in the
nucleolus, there may be a dynamic coordination, both spatially
and temporally, that regulates their functions from the transcrip-
tion of rDNA to the assembly and export of preribosomal
particles. Here we summarize most of the described regulations
on ribosome biogenesis in the nucleolus. However, these may
represent only a small fraction of a larger picture. Further studies
are required to determine the initial signals, signal transduction
pathways utilized, and the specific targets of these regulatory
modifications and how these are used to control ribosome
biogenesis as a whole. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
The mature 80S eukaryotic ribosome consists of two sub-
units, the 60S (large) subunit and 40S (small) subunit. The
two subunits together contain approximately 80 ribosomal
proteins that are organized around highly modi¢ed ribosomal
RNAs (rRNAs). The synthesis and assembly of a complete
ribosome involves a complex series of pathways that occur
throughout the cell. All three types of RNA polymerase are
involved in the synthesis of ribosomal components. RNA
polymerase I (Pol I) is dedicated to the synthesis of the 28S,
18S, and 5.8S rRNAs, RNA polymerase III synthesizes the
remaining 5S rRNA as well as small RNAs that are necessary
for various steps of ribosomal biogenesis, and RNA polymer-
ase II synthesizes the pre-mRNAs for ribosomal proteins. The
majority of these building blocks come together in the nucle-
olus where they are assembled into preribosomal particles.
These complexes traverse the nucleoplasm, exit the nucleus
through nuclear pores, and become mature ribosomes in the
cytoplasm (see Fig. 1).
The protein synthesis mediated by ribosomes is crucial to
cell growth, proliferation, and adaptation to changing envi-
ronments. It has been estimated that a growing HeLa cell
produces about 7500 ribosomal subunits per minute, which
requires approximately 300 000 ribosomal proteins and nu-
merous associations and dissociations with trans-acting fac-
tors (non-ribosomal proteins) [1], putting an immense demand
on cellular machinery. Therefore, ribosomal biogenesis is
closely regulated at multiple levels (see Table 1 and Fig. 1).
Although the factors and steps involved in ribosomal biogen-
esis have been extensively studied, the mechanisms that regu-
late this process in response to growth conditions are not well
understood. As other reviews have adequately covered the
regulation of ribosomal protein production [2^5] and tran-
scription by RNA polymerase III [6,7], this review will focus
on the regulation of ribosome biogenesis within the nucleolus.
2. Transcription of ribosomal DNA
Although not all ribosomal DNA (rDNA) repeats are uti-
lized at any given moment, synthesis of pre-rRNA is a highly
active process and rRNA can constitute up to 80% of total
RNA in a cell [8]. rDNA transcription is believed to occur on
the border of ¢brillar centers and the dense ¢brillar compo-
nents of nucleoli [9]. Studies using in vitro reconstituted sys-
tems demonstrated that initiation of the transcription of
rDNA requires selectivity factor 1 (SL-1), upstream binding
factor (UBF), RRN3, Pol I subunits, and other cofactors (for
complete reviews see [8,10,11]). More recent data using cell-
free systems suggest that initiation complex formation is a
stepwise process involving chromatin remodeling before or
after the initial recruitment of SL-1 to the promoter, followed
by association of RRN3 and Pol I subunits to form the pre-
initiation complex [12,13]. However, an opposing model envi-
sions that Pol I binds to rDNA and initiates transcription as a
preassembled holoenzyme [14^16]. In either model, SL-1 and
UBF are believed to remain promoter-bound following pro-
moter clearance by Pol I. Promoter clearance is suggested to
be the rate-limiting step in the transcription of rDNA [13,17].
Since these studies have been done predominantly in vitro, the
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precise mechanism of the transcription of rDNA in vivo re-
mains to be clari¢ed.
The regulation of pre-rRNA synthesis is a major control
point in ribosome biogenesis. Pre-rRNA synthesis is down-
regulated in response to nutrient starvation, di¡erentiation,
or inhibition of protein synthesis, and is upregulated upon
re-addition of nutrients, or growth or proliferation stimuli
(for reviews see [8,10,11]). Regulation could take place at
multiple stages in the process, including chromatin remodel-
ing, transcriptional factor activation, initiation, elongation,
and termination. Studies in the past few years have begun
to address the mechanisms that act at these regulatory points
and their relationship to the level of ribosome biogenesis.
There are excess amounts of the Pol I transcriptional fac-
tors, but it is apparent that not all of these proteins are func-
tionally active at all times. The functional status of a protein
could be regulated through a number of mechanisms. Those
so far described include phosphorylation, acetylation, and
protein^protein interactions. Many of the factors involved in
the transcription of rDNA are phosphoproteins. For example,
the multifunctional protein nucleolin, which is also involved in
pre-rRNA processing, binds to the spacer regions between
rDNA repeats and increases the speci¢city of the transcription
of rDNA, apparently by remodeling chromatin [18]. This
function requires phosphorylation of nucleolin by casein ki-
nase II (CKII), an event coordinated with cell growth and
regulated by signal transduction pathways [18]. CKII has
also been shown to phosphorylate UBF [19^21], resulting in
increased transcription of rDNA in interphase cells, apparent-
ly by enhancing the interaction of UBF and SL-1 [21,22].
Phosphorylation of UBF [23,24] and SL-1 [25,26] by cdc2
kinase during mitosis and early G1 has the opposite e¡ect
and inhibits the interaction of these proteins resulting in in-
hibition of the transcription of rDNA. Cdc2 kinase also phos-
phorylates the initiation and transcription termination factor
TTF-1, reducing its chromatin-binding a⁄nity and contribut-
ing to mitotic rDNA silencing [27]. Pol I itself can be puri¢ed
as a holoenzyme containing CKII [28] and CKII may directly
phosphorylate Pol I, though the e¡ect of this phosphorylation
on Pol I activity is not yet clear [8,28]. In addition, DNA-
activated protein kinase, a trimeric protein that contains the
rDNA promoter-binding protein Ku, can inhibit initiation of
the transcription of rDNA through modi¢cation of an as yet
unidenti¢ed substrate [29,30]. These studies demonstrate that
phosphorylation of proteins involved in the transcription of
rDNA provides both positive and negative regulation of pre-
rRNA synthesis.
Covalent modi¢cation through acetylation and methylation
also plays roles in regulating the transcription of rDNA at
multiple levels. At the chromatin level, hypermethylated
DNA and histone deacetylation contribute to rDNA silencing
[8,31] while, conversely, histone hypomethylation and histone
acetylation result in the activation of rDNA transcription [32^
34]. Though the factors that mediate methylation-induced
rDNA silencing are unknown, there are several linkages be-
tween Pol I transcription factors and histone-modifying en-
zymes. Both the tumor suppressor retinoblastoma protein
(pRb) [35] and the regulator of nucleolar silencing and telo-
phase exit (RENT) complex component Net1 [36], which di-
rectly associate with components of the Pol I machinery, bind
to and may recruit histone deacetylases to rDNA repeats,
resulting in rDNA silencing. In opposition to the silencing
e¡ects of deacetylases, a histone acetyltransferase (HAT) has
been copuri¢ed with Pol I from Xenopus [37], though modi¢-
cation of rDNA by this HAT has not yet been demonstrated.
More recently, acetylation of Pol I transcription factors has
also been documented and overexpression of several transace-
tylases has been shown to stimulate rDNA transcription [34].
Fig. 1. Diagrammatic representation of the steps and corresponding points of regulation in ribosome biogenesis. Functional steps are listed in
red with the trans-acting factors involved shown to their right in green. The substrates/products of the biogenic steps are listed in blue.
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UBF is acetylated in vivo [34] and can be acetylated in vitro
by the acetyltransferase CREB-binding protein (CBP) [38].
The acetylated UBF is more active leading to enhanced ini-
tiation of the transcription of rDNA [38]. In addition, SL-1
can be acetylated by p300/CBP-associated factor, an acetyl-
transferase recruited by TTF-1. Acetylated SL-1 initiates the
transcription of rDNA more e⁄ciently than the non-acety-
lated form [39]. Based on these studies, it appears that acety-
lation of both rDNA-associated histones and Pol I transcrip-
tion factors enhances the transcription of rDNA.
There are also two prominent but less well-characterized
examples of apparent covalent modi¢cations that a¡ect the
transcription of rDNA. The Pol I cofactor RRN3, which is
required for initiation, is active in vitro when isolated from
exponentially growing cells but is inactive when isolated from
starved or cycloheximide-treated cells [40]. This indicates that
its activity may be post-translationally regulated, though the
mechanism is unclear. The core promoter-binding factor
(CPBF)/USF1, which interacts with Ku, forms heterodimers
with USF2 [41]. While the DNA-binding a⁄nity of USF pro-
teins can be regulated by cdc2 kinase [42], their role in regu-
lation of the transcription of rDNA appears to be mediated
by their dimerization. Heterodimers of USF1 and 2 enhance
the transcription of rDNA both in vitro and in vivo while
homodimers of either protein inhibit transcription and cellular
proliferation [43,44]. The importance of these factors in regu-
lation of Pol I and the interplay between them requires further
study.
Table 1
List of nucleolar substrates and factors involved in ribosomal biogenesis, their function, the mechanisms used to regulate them and the e¡ect of
these regulations on the listed function
Substrate/factor Function Regulatory mechanisms Functional
e¡ect
Pol I transcription
Chromatin remodeling of rDNA
rDNA Template for rRNA synthesis Methylation [8,31^34] 3
Histones Activation of rDNA transcription Acetylation [8,31^34] +
Nucleolin (Nsr1p) Binds rDNA spacer regions, enhances Pol I speci¢city Phosphorylation [18] +
TTF-1 Termination and initiation factor Phosphorylation [27] +/3
Pol I and cofactors
RNA polymerase I Transcription of rDNA Phosphorylation [8,28] +
Protein^protein interaction [36,45,46] Unclear
Tra⁄cking [PC] Unclear
UBF Transcription factor required for Pol I initiation Phosphorylation [19^24] +/3
Acetylation [34,38] +/3
Protein^protein interaction [47^51] +/3
Tra⁄cking [74] Unclear
SL-1 Transcription factor required for Pol I initiation Phosphorylation [19,20] 3
Acetylation [30] +
Protein^protein interaction [52] 3
RRN3 Required for Pol I initiation Unclear [40] Unclear
CPBF (USF1) and USF2 rDNA promoter-binding proteins Phosphorylation [42^44] Unclear
rRNA processing, assembly and tra⁄cking
Nucleases
Csl4p 3PC5P Exoribonuclease Expression level [55] 3 (Unclear)
Pop3p Component of RNase P and RNase MRP Expression level [55] 3 (Unclear)
Rpp29 Component of RNase MRP Tra⁄cking [74] Unclear
snoRNP proteins
Imp4p U3 snoRNP component Expression level [55] +/3 (Unclear)
Nop1p (¢brillarin) C/D box snoRNP component, putative methyltransferase Expression level [58] +/3 (Unclear)
Tra⁄cking [74^76] Unclear
Nop56p/Sik1p C/D box snoRNP component Expression level [58] 3 (Unclear)
Nop58p/Nop5p C/D box snoRNP component Expression level [58] 3 (Unclear)
Nhp2p H/ACA box snoRNP component Expression level [58] 3 (Unclear)
Srp40p (Nopp140) Putative snoRNP chaperone Phosphorylation [46,61] Unclear
Helicases
Dbp3p Acts in 60S subunit synthesis Expression level [58] 3 (Unclear)
Other factors
Ebp2 Involved in processing and 60S assembly, required for
PKC-mediated response to secretory defects
Unclear [67] Unclear
Erb1p (Bop1p) Involved in 60S subunit processing and assembly Expression level [56] 3 (Unclear)
Nip7p Putatively involved in late preribosomal particle assembly Expression level [58] 3 (Unclear)
Nsr1p (nucleolin) Involved in processing, assembly and possibly tra⁄cking Expression level [55,58^60] +/3 (Unclear)
Phosphorylation [62,64] Unclear
Tra⁄cking [65] Unclear
Nucleophosmin/B23/NO38 Binds preribosomal particles, may act in tra⁄cking Expression level [55] + (Unclear)
Phosphorylation [54,65] + (Unclear)
Tra⁄cking [74] Unclear
Rrs1 Involved in processing and 60S assembly, required for
PKC-mediated response to secretory defects
Unclear [68] Unclear
Numbers in brackets in the Regulatory mechanisms column are citations, PC stands for personal communication. In the Functional e¡ect col-
umn, ‘+’ indicates an enhancement of the given function, ‘3’ indicates impairment of function, and ‘+/3’ indicates that the mechanism can ei-
ther enhance or impair protein function. The presence of ‘Unclear’ indicates that the mechanism/e¡ect is either unclear (if not in parentheses)
or has not been experimentally tested (if in parentheses).
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In addition, the functional status of a transcription factor
can also be regulated through protein^protein interactions
that either enhance or inhibit its activity. For example, direct
interaction with Net1 appears necessary to position Pol I at
sites of transcription. Net1, along with other components of
the RENT complex, Sir2 and Cdc14, is required to maintain
nucleolar structure and enhances the transcription of rDNA
in vivo [36,45]. Nopp140 (Srp40p in yeast) also binds to Pol I
and possibly enhances Pol I activity, as the transcription of
rDNA is inhibited when full-length or dominant-negative
Nopp140 is overexpressed [46]. In contrast, the binding of
the interferon-inducible protein p204 [47] to UBF inhibits
the transcription of rDNA and may prevent the transcription
factor from binding DNA. Other studies have shown that the
binding of pRb to UBF, either by reducing the DNA-binding
a⁄nity of UBF [48] or by preventing the interaction between
SL-1 and UBF [49], can inhibit rDNA transcription in vitro
[48] and in vivo [50,51]. Another tumor suppressor, p53, has
been shown to bind SL-1 directly and also prevents the inter-
action between SL-1 and UBF, thereby suppressing initiation
of the transcription of rDNA [52]. The interactions between
Pol I transcriptional factors and pRb or p53 provide contact
points with proteins which have widespread e¡ects on cellular
processes and are themselves regulated by multiple signaling
pathways. Thus, although these interactions have not been
fully characterized in vivo, they may provide important link-
ages between numerous signaling pathways and the transcrip-
tion of rDNA.
3. Regulation of pre-rRNA processing and preribosomal
particle assembly
Once pre-rRNA has been synthesized as a large precursor
molecule, multiple cleavages, modi¢cations, and assembly
steps are required to produce mature rRNAs that are associ-
ated with the proper ribosomal proteins (for comprehensive
reviews see [53,54]). Conserved sites on pre-rRNA are cleaved
by endo- and exonucleases and methylation is carried out by
either conserved methyltransferases or C/D box small nucleo-
lar ribonucleoproteins (snoRNPs) consisting of stable snoR-
NAs and protein components. Particular residues are pseu-
douridylated by the H/ACA box snoRNPs. RNA helicases
of the DEAD box and related families are necessary for pro-
cessing and assembly, possibly by unwinding RNA duplexes,
displacing protein factors, and/or creating RNA structure nec-
essary for subsequent steps [53]. While the processing of pre-
rRNA proceeds, both the trans-acting factors and the major-
ity of the ribosomal proteins are assembled onto the pre-
rRNA in a cooperative manner. These preribosomal particles
are thought to move from the dense ¢brillar component to the
granular component parallel with their processing and the
particles enter the nucleoplasm prior to subunit separation
and export.
Although the steps and mechanisms involved in processing
pre-rRNA have been extensively investigated, the overall reg-
ulation of and coordination between the processing and as-
sembly of preribosomal particles is not well understood. The
involvement of a large number of cellular components and of
multiple steps provides numerous opportunities for coordina-
tion and regulation. Since processing, assembly, and tra⁄ck-
ing cannot be reconstituted in vitro, nor can they be easily
separated or manipulated, the interplay among the regulations
of many processing and assembly factors is still unclear. Most
of the evidence for the regulation of processing of pre-rRNA
and preribosomal particle assembly comes from studies using
the yeast genetic system, thus yeast nomenclature will be used
in this section.
Regulation at the expression levels of components involved
in processing of pre-rRNA preribosomal particle assembly has
been shown to occur in response to many cellular signals. For
example, when yeast enter stationary phase and ribosome bio-
synthesis is inhibited, there is a signi¢cant decrease of the level
of mRNA encoding the essential 3PC5P exoribonuclease
Csl4p, the RNase P and RNase MRP component Pop3p,
and the late preribosomal RNA processing and particle as-
sembly factor Nsr1p (nucleolin) [55]. When ribosome biosyn-
thesis is inhibited by serum starvation of mammalian cells, the
mRNA levels of the processing and assembly protein Erb1p
(Bop1p) are reduced [56]. A recent study has demonstrated
that expression of dominant-negative Bop1p can induce a
p53-mediated cell cycle arrest [57], providing a possible link-
age between multiple steps of ribosome biogenesis and the cell
cycle. Other treatments that can inhibit ribosome biogenesis,
including glucose depletion, heat shock, and nitrogen starva-
tion, decrease the mRNA level of the U3 snoRNP component
Imp4p [55]. In addition, treatment of cells with the alkylating
agent methyl methanesulfonate, which creates DNA damage
and stabilizes p53, reduces the mRNA level of C/D box pro-
teins Nop1p (¢brillarin), Nop56p/Sik1p, Nop58p/Nop5p, the
H/ACA box protein Nhp2p, the DEAD box helicase Dbp3p,
and the late preribosomal RNA processing and particle as-
sembly factors Nip7p and Nsr1p (nucleolin) [58]. Such regu-
lation may represent a multifaceted inhibition of ribosome
biogenesis in response to DNA damage. On the other hand,
transcription factor Myc can increase the mRNA level of both
Nsr1p/nucleolin and nucleophosmin (B23/NO38), another
multifunctional protein involved in both assembly and intra-
nuclear tra⁄cking of preribosomal particles [59,60]. In gener-
al, changes in the level of expression of processing factors
coincide with the level of ribosome biogenesis, but the speci¢c
e¡ects of such alterations on ribosome biogenesis are not
clear. In addition, the signaling pathways and components
that link cellular changes to regulation of the expression of
these factors also need to be addressed.
Control through covalent modi¢cation may also play a role
in regulating processing of pre-rRNA and assembly of preri-
bosomal particles, since several of the trans-acting factors are
phosphoproteins. For example, the H/ACA box and C/D box
snoRNP-associated protein Srp40p (Nopp140), which may act
as a snoRNP chaperone, interacts with and is phosphorylated
by CKII [61]. Srp40p can be extensively phosphorylated in
both yeast and mammalian cells, but how phosphorylation
a¡ects its interaction with snoRNPs or its functional status
is unclear [46]. Like Srp40p/Nopp140, Nsr1p/nucleolin [62]
and nucleophosmin [63] are phosphorylated by CKII in inter-
phase cells. However, unlike Srp40p/Nopp140, Nsr1p/nucleo-
lin [64] and nucleophosmin [65] are also phosphorylated by
cdc2 kinase during mitosis when ribosome biogenesis is inhib-
ited. Phosphorylation by di¡erent kinases at di¡erent stages of
the cell cycle, therefore, could have opposite e¡ects on ribo-
some biogenesis. Since both CKII and cdc2 kinase also phos-
phorylate factors involved in the transcription of rDNA, it
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will be of interest to explore both the individual and cumu-
lative e¡ects of these kinases and the upstream signaling path-
ways that lead to these modi¢cations.
One signaling pathway that has been shown to regulate
processing of pre-rRNA and preribosomal particle assembly
is the protein kinase C (PKC) pathway [66]. Defects in the
secretory pathway that is required for membrane synthesis
during growth have been found to inhibit ribosome biogenesis
in yeast through the PKC pathway. Genetic analyses demon-
strate that this inhibitory activity requires the processing and
assembly factors Ebp2 and Rrs1 [67,68]. However, the con-
nections between PKC and these proteins as well as their
regulatory modi¢cations that result in the inhibition of pro-
cessing and assembly are not yet understood.
Once preribosomal particles are su⁄ciently processed and
assembled in the nucleolus, they move into the nucleoplasm
prior to nuclear export. Using a yeast genetic system, a recent
study by Milkereit et al. [69] demonstrated that the translo-
cation of the 66S preribosomal particle into the nucleoplasm
might be mediated by the transition from Noc1p- and Noc2p-
associated particles to Noc2p- and Noc3p-associated particles.
The factors involved in 43S preribosomal particle tra⁄cking
and export have not yet been identi¢ed. Since ribosome bio-
genesis is highly spatially de¢ned, the intranuclear tra⁄cking
of assembled preribosomes may also represent an important
regulatory stage in this process.
4. Intranuclear tra⁄cking
Although there is an increasing amount of evidence dem-
onstrating the elaborate and complex regulation of the tran-
scription of rDNA, processing of pre-rRNA, and preribosom-
al particle assembly, the spatial organization of the covalent
modi¢cations and protein^protein interactions as described
above remains unclear. Since most of the factors involved in
ribosome biogenesis localize predominantly to the nucleolus
at steady state whereas many of the known modi¢ers, includ-
ing CKII [70], CBP [71], pRb [72] and p53 [73], are predom-
inantly nucleoplasmic, it is di⁄cult to envision the spatial
organization of these modi¢cations or interactions. Several
recent studies have begun to address this aspect in vivo. Fluo-
rescence recovery after photobleaching (FRAP) analyses using
green £uorescent protein-tagged proteins in living cells
showed that nucleolar proteins involved in the transcription
of rDNA, processing of pre-rRNA, and assembly of preribo-
somal particles cycle rapidly between nucleoli and the nucle-
oplasm. This intranuclear shuttling appears to be related to
the functions of these proteins, as inhibition of the transcrip-
tion of rDNA a¡ects their shuttling kinetics. The transcrip-
tional factors examined include UBF [74] and Pol I compo-
nents (Dundr and Misteli, personal communication). The
proteins involved in pre-rRNA processing and preribosomal
particle assembly that were examined include Nop1p/¢brillar-
in [74^76], Nsr1p/nucleolin, RNase MRP protein, and nucle-
ophosmin [74]. It is our view (Fig. 1) that the relatively rapid
exchange of these factors between the densely packed nucleo-
lus and nucleoplasm may represent a stage of regulation for
these factors. The exchange provides spatial and temporal
opportunities for contact between the trans-acting factors
and their modi¢ers. After each round of function, factors
would exit nucleoli to be modi¢ed, reactivated and/or form
complexes with other cellular factors in the nucleoplasm. The
functionally active form of the trans-acting factors would be
competent to reenter nucleoli and to engage in transcriptional
activation, processing of pre-rRNA, or preribosomal particle
assembly. This model is supported by the ¢nding that a
C-terminal deletion of UBF1, which abolishes its function in
transcriptional activation and prevents the protein from enter-
ing the nucleolus [77], also signi¢cantly impairs its mobility as
measured by FRAP analyses (D. Chen and S. Huang, unpub-
lished observations). Whether this model truly represents the
regulatory activities that take place in the nucleus requires
future testing.
5. Summary
Ribosome biogenesis is a complex and tightly regulated
process. There are numerous points and steps where regula-
tions could take place. To incorporate all these regulations
may require elaborate temporal and spatial coordination of
a large number of processes. The experimental data we have
summarized here begin to reveal the complexity of the regu-
lation of ribosome biogenesis. However, they may only repre-
sent a small fraction of a much larger picture. Further studies
are needed to determine the initial signals, signal transduction
pathways utilized, and the speci¢c targets of these regulatory
modi¢cations on the steps of ribosome biogenesis and the
process as a whole.
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